Dr. Kamran Idrees, MD

Claim this profile

Vanderbilt University/Ingram Cancer Center

Studies Carcinoid Tumor
Studies Neuroendocrine Tumors
1 reported clinical trial
2 drugs studied

Area of expertise

1Carcinoid Tumor
Kamran Idrees, MD has run 1 trial for Carcinoid Tumor. Some of their research focus areas include:
Stage IV
Somatostatin receptor avidity positive
2Neuroendocrine Tumors
Kamran Idrees, MD has run 1 trial for Neuroendocrine Tumors. Some of their research focus areas include:
Stage IV
Somatostatin receptor avidity positive

Affiliated Hospitals

Image of trial facility.
Vanderbilt University/Ingram Cancer Center

Clinical Trials Kamran Idrees, MD is currently running

Image of trial facility.

Targeted Radiation Therapy Post-Surgery

for Metastatic Neuroendocrine Tumors

This phase IV trial evaluates how well giving standard of care (SOC) peptide receptor radionuclide therapy (PRRT) after SOC surgical removal of as much tumor as possible (debulking surgery) works in treating patients with grade 1 or 2, somatostatin receptor (SSTR) positive, gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that have spread from where they first started (primary site) to the liver (hepatic metastasis). Lutetium Lu 177 dotatate is a radioactive drug that uses targeted radiation to kill tumor cells. Lutetium Lu 177 dotatate includes a radioactive form (an isotope) of the element called lutetium. This radioactive isotope (Lu-177) is attached to a molecule called dotatate. On the surface of GEP-NET tumor cells, a receptor called a somatostatin receptor binds to dotatate. When this binding occurs, the lutetium Lu 177 dotatate drug then enters somatostatin receptor-positive tumor cells, and radiation emitted by Lu-177 helps kill the cells. Giving lutetium Lu 177 dotatate after surgical debulking may better treat patients with grade 1/2 GEP-NETs
Recruiting3 awards Phase 415 criteria

More about Kamran Idrees, MD

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Kamran Idrees, MD has experience with
  • Lutetium Lu 177 Dotatate
  • Tumor Debulking
Breakdown of trials Kamran Idrees, MD has run
Carcinoid Tumor
Neuroendocrine Tumors
Liver Cancer
Pancreatic Neuroendocrine Tumors
Pancreatic Cancer

Other Doctors you might be interested in

Michael C. TopfVanderbilt University Medical Center
Alan TanRush University Medical Center
Michael Savona, MDVanderbilt University Medical Center

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kamran Idrees, MD specialize in?
Kamran Idrees, MD focuses on Carcinoid Tumor and Neuroendocrine Tumors. In particular, much of their work with Carcinoid Tumor has involved Stage IV patients, or patients who are Somatostatin receptor avidity positive.
Is Kamran Idrees, MD currently recruiting for clinical trials?
Yes, Kamran Idrees, MD is currently recruiting for 1 clinical trial in Nashville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Kamran Idrees, MD has studied deeply?
Yes, Kamran Idrees, MD has studied treatments such as Lutetium Lu 177 Dotatate, Tumor Debulking.
What is the best way to schedule an appointment with Kamran Idrees, MD?
Apply for one of the trials that Kamran Idrees, MD is conducting.
What is the office address of Kamran Idrees, MD?
The office of Kamran Idrees, MD is located at: Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee 37203 United States. This is the address for their practice at the Vanderbilt University/Ingram Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top